Jiayu Zhu

Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction

Jiayu Zhu, Mei Zhong, Zhan-Jun Pang et al. · Early Human Development · 2014 · 50 citations

Fetal Growth Restriction, Developmental Biology, Matrix Metalloproteinases +11

Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective study

Jiayu Zhu, Chengcheng Liu, Liang Wang et al. · Journal of Cancer · 2017 · 42 citations · Full text

Surgical Oncology, Prognosis, Immunology +17

The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study

Jiayu Zhu, Hua Wang, Cheng‐Cheng Liu et al. · Journal of Cancer Research and Clinical Oncology · 2016 · 36 citations · Full text

Prognostic Evaluation, Prognostic Biomarkers, Medicine +9

Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study

Hua Wang, Zhi-jun Wu-Xiao, Jiayu Zhu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 31 citations

Optimal Chemotherapy Regimen, First-line Chemotherapy, Lymphoid Neoplasia +15

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway

Yanlin Cai, Yi Hu, Furong Yu et al. · Aging · 2021 · 27 citations · Full text

Ahnak Contents, Signaling Pathway, Endocrine-related Cancer +13